Oxybutynin Chloride Tablet
Product Images NDC 0832-0038

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 0832-0038). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Oxybutynin 01)

FDA Label Image

Figure 1 (Oxybutynin 02)

FDA Label Image

Figure 2 (Oxybutynin 03)

FDA Label Image

Principal Display Panel (5 mg Tablet Blister Pack Carton)

Principal Display Panel (5 mg Tablet Blister Pack Carton)
Oxybutynin Chloride is a medication available in tablet form. Each tablet contains 5mg of the active ingredient. This package contains 100 tablets in unit-dose packaging. The recommended dosage is described in the package insert. Storage instructions indicate that this medication should be kept at 20°C to 25°C. The package is designed for institutional use only and is not child-resistant. It should not be used in households and should be kept out of the reach of children. The package is manufactured by Upsher-Smith Laboratories in Minnesota.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.